Thor Medical ASA (LTS:0R6Y) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Thor Medical ASA's Free Cash Flow for the three months ended in Dec. 2023 was kr0.00 Mil. Thor Medical ASA's Revenue for the three months ended in Dec. 2023 was kr0.00 Mil. Therefore, Thor Medical ASA's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Thor Medical ASA's current FCF Yield % is -26.19%.

The historical rank and industry rank for Thor Medical ASA's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Thor Medical ASA was -13618.00%. The lowest was -83424.83%. And the median was -50162.13%.

LTS:0R6Y's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -143.92
* Ranked among companies with meaningful FCF Margin % only.

Thor Medical ASA FCF Margin % Historical Data

The historical data trend for Thor Medical ASA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA FCF Margin % Chart

Thor Medical ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

Thor Medical ASA Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Thor Medical ASA's FCF Margin %

For the Biotechnology subindustry, Thor Medical ASA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's FCF Margin % falls into.

Thor Medical ASA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Thor Medical ASA's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-64.09	/	0
	=	%

Thor Medical ASA's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0
	=	%

Thor Medical ASA FCF Margin % Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA (LTS:0R6Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (LTS:0R6Y) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

TRMED:Norway 8NN:Germany

Address

Kjelsasveien 168 B, Oslo, NOR, 0884

Website

https://www.nordicnanovector.com

Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (LTS:0R6Y) Headlines

No Headlines